STOCK TITAN

Amer Shared Hosp - AMS STOCK NEWS

Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.

American Shared Hospital Services (AMS): Revolutionizing Cancer Treatment with Advanced Technology

American Shared Hospital Services (AMS) is a leading provider of innovative financial and turnkey solutions to cancer treatment centers, hospitals, and large cancer networks worldwide. With over 100 years of industry expertise, AMS specializes in delivering cutting-edge radiosurgery and radiation therapy equipment, enabling healthcare providers to offer state-of-the-art cancer treatments without the need for significant upfront capital investment. The company’s mission is to empower medical centers with access to advanced technologies, ensuring better patient outcomes and improved operational efficiency.

Core Business Areas

AMS operates through three primary segments:

  • Gamma Knife Operations: AMS provides Leksell Gamma Knife systems, a non-invasive radiosurgery solution for treating intracranial tumors and lesions with unparalleled precision. This technology minimizes impact on healthy tissues, safeguarding motor, sensory, and neurocognitive functions.
  • Advanced Radiation Therapy Equipment and Services: The company offers advanced digital linear accelerators, MR-guided radiation therapy systems, and brachytherapy solutions, catering to diverse treatment needs.
  • Proton Beam Radiation Therapy: AMS facilitates access to proton beam therapy, a cutting-edge modality for targeting cancer cells with minimal side effects.

Innovative Financing Solutions

AMS’s unique value proposition lies in its ability to provide creative financial arrangements, including leasing and joint ventures, that allow healthcare providers to adopt advanced medical technologies without the financial burden of direct ownership. Through its subsidiary, GK Financing LLC, AMS collaborates with major Original Equipment Manufacturers (OEMs) like Elekta to deliver vendor-agnostic solutions tailored to the specific needs of its partners.

Global Footprint and Market Expansion

While AMS generates most of its revenue from the domestic market, it has strategically expanded its operations internationally. Notable ventures include partnerships in Mexico, Peru, and Ecuador, where the company has introduced advanced treatment modalities like the Elekta Gamma Knife Esprit and Versa HD Linear Accelerators. These initiatives address critical gaps in cancer care, particularly in underserved regions, by offering non-invasive and patient-friendly treatment options.

Commitment to Innovation and Patient Care

AMS continually invests in upgrading its technology portfolio to meet the evolving needs of healthcare providers and patients. Recent advancements, such as the Elekta Gamma Knife Esprit system, enhance treatment precision, workflow efficiency, and patient outcomes. These innovations exemplify AMS’s commitment to improving the quality of life for cancer patients worldwide.

Challenges and Competitive Landscape

Operating in the highly specialized field of radiosurgery and radiation therapy, AMS faces competition from other medical technology providers and financial solution firms. However, its vendor-agnostic approach, focus on non-invasive treatment technologies, and ability to customize financial solutions position it uniquely in the market. By addressing both technological and financial barriers, AMS continues to differentiate itself as a trusted partner for healthcare providers globally.

Why AMS Matters

By bridging the gap between cutting-edge technology and financial accessibility, AMS plays a pivotal role in advancing cancer treatment. Its partnerships with leading hospitals and cancer centers, combined with its focus on patient-centric care, make it a significant player in the healthcare industry. For investors, AMS represents a company with a strong foundation, innovative business model, and growth potential driven by global expansion and technological advancements.

Rhea-AI Summary
American Shared Hospital Services (NYSE American: AMS) expands its U.S. footprint by acquiring a 60% majority equity interest in the Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC, as well as certain payor contracts, from GenesisCare USA, Inc. for $2.85 million. This acquisition adds three fully functional turn-key radiation therapy cancer centers in Rhode Island, equipped with state-of-the-art cancer treatment technology, and is expected to be accretive to the company's base. The transaction is subject to bankruptcy court approval and other customary closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
American Shared Hospital Services (NYSE American: AMS) announced an increase in the sales pipeline, 2 lease extensions, and advancements in international cancer center equipment upgrades. Financial results for Q3 2023 showed a 6.3% increase in total revenue, with gross margin at 40.9% of revenue. The company reported net income of $118,000, or $0.02 per diluted share, and cash at September 30, 2023, was $14,655,000. The sales pipeline growth, lease extensions, and international equipment upgrades are expected to drive future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.36%
Tags
-
Rhea-AI Summary
AMS to Hold Quarterly Conference Call to Discuss Third Quarter 2023 Financial Results on November 13th, 2023 at 4:30 pm ET / 1:30 pm PT
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
Rhea-AI Summary
GK Financing LLC celebrates 20th anniversary of first patient treated with Stereotactic Radiosurgery Surgery in Peru. Dr. Aldo Berti hosts event with expert clinicians. Gamma Knife Esprit to be installed, offering new clinical features. GKF to have booth at ASTRO meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
none
-
Rhea-AI Summary
American Shared Hospital Services (ASHS) and GK Financing LLC (GKF) will exhibit at the ASTRO annual meeting, showcasing their financial and turnkey solutions for advanced radiosurgery and radiation oncology services. This opportunity allows them to directly market their offerings and meet with current customers, prospects, strategic partners, and major OEMs. ASHS and GKF aim to educate attendees on obtaining the latest medical treatment devices with no capital outlay. The presence of three major societies at the event provides an opportunity to meet decision-makers and medical experts in the field. ASHS and GKF will have staff available at booth #2427 to discuss how they can bring the latest medical treatment technology to hospitals and cancer centers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
conferences
-
Rhea-AI Summary
GKF completes upgrade of Gamma Knife Perfexion to Gamma Knife ICON at Providence Swedish Radiosurgery Center
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none
Rhea-AI Summary
GKF extends agreement with Methodist Hospital to upgrade Gamma Knife Perfexion to Gamma Knife Esprit, expects installation in October 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
none
-
Rhea-AI Summary
GK Financing LLC, a subsidiary of American Shared Hospital Services, has launched a new website that aims to revolutionize the way healthcare professionals in neuroscience and radiosurgery access financing alternatives for the Gamma Knife. The website provides information about the benefits and advancements of Elekta Esprit for treatments and a patient's guide to Gamma Knife Radiosurgery. Gamma Knife radiosurgery is a non-invasive technique that uses targeted radiation beams to treat brain disorders. GKF offers financing solutions with no capital outlay and no monthly minimums.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
none

FAQ

What is the current stock price of Amer Shared Hosp (AMS)?

The current stock price of Amer Shared Hosp (AMS) is $2.76 as of March 6, 2025.

What is the market cap of Amer Shared Hosp (AMS)?

The market cap of Amer Shared Hosp (AMS) is approximately 17.7M.

What does American Shared Hospital Services (AMS) specialize in?

AMS specializes in providing radiosurgery and radiation therapy equipment, including Gamma Knife and Proton Beam Therapy systems, along with innovative financial solutions for healthcare providers.

How does AMS generate revenue?

AMS generates revenue through equipment leasing, joint ventures, and turnkey solutions for hospitals and cancer centers, enabling them to adopt advanced medical technologies without upfront capital investment.

What is the Gamma Knife technology provided by AMS?

The Gamma Knife is a non-invasive radiosurgery system used to treat intracranial tumors and lesions with high precision, minimizing impact on healthy tissue and preserving neurocognitive functions.

What is AMS’s approach to global expansion?

AMS has expanded internationally through joint ventures in regions like Mexico, Peru, and Ecuador, introducing advanced treatment technologies to underserved areas and addressing critical gaps in cancer care.

How does AMS differentiate itself from competitors?

AMS stands out with its vendor-agnostic approach, innovative financing solutions, and focus on non-invasive cancer treatments, enabling healthcare providers to access cutting-edge technology without financial burden.

What role does GK Financing LLC play in AMS’s operations?

GK Financing LLC, a subsidiary of AMS, facilitates financial arrangements and partnerships with OEMs to provide advanced medical equipment like the Leksell Gamma Knife to healthcare providers.

What are the benefits of AMS’s financial solutions for hospitals?

AMS’s financial solutions, such as leasing and joint ventures, allow hospitals to adopt advanced medical technologies without significant upfront costs, improving patient care and operational efficiency.

What is Proton Beam Therapy, and how does AMS support it?

Proton Beam Therapy is a cutting-edge cancer treatment modality that targets tumors with high precision and minimal side effects. AMS provides financial and operational support to hospitals adopting this technology.

What challenges does AMS face in its industry?

AMS faces competition from other medical technology providers and financial firms, as well as challenges related to regulatory changes and market dynamics. However, its vendor-agnostic and patient-focused approach helps mitigate these challenges.

What is AMS’s commitment to innovation in cancer treatment?

AMS is committed to advancing cancer treatment by continually upgrading its technology portfolio, such as the Elekta Gamma Knife Esprit system, to enhance treatment precision and patient outcomes.
Amer Shared Hosp

NYSE:AMS

AMS Rankings

AMS Stock Data

17.72M
3.48M
38.87%
16.99%
0.48%
Medical Care Facilities
Services-medical Laboratories
Link
United States
SAN FRANCISCO